Transition metal-catalyzed N-arylation of amides constitutes a powerful CÀN bond-forming process that has been extensively utilized in pharmaceutical and medicinal chemistry.[1] Despite remarkable advances in both palladium-[2] and copper-catalyzed [3] reactions of this type, the development of alternative catalysts involving more cost-efficient, nontoxic, and environmentally friendly metals to effect the target process remains an issue of scientific ...